These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 3381266

  • 1. Treatment of endogenous uveitis with cyclosporine A.
    BenEzra D, Cohen E, Rakotomalala M, de Courten C, Harris W, Chajek T, Friedman G, Matamoros N.
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):122-7. PubMed ID: 3381266
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of conventional therapy versus cyclosporine A in Behçet's syndrome.
    BenEzra D, Cohen E, Chajek T, Friedman G, Pizanti S, de Courten C, Harris W.
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):136-43. PubMed ID: 3381269
    [Abstract] [Full Text] [Related]

  • 3. Comparison of infliximab versus ciclosporin during the initial 6-month treatment period in Behçet disease.
    Yamada Y, Sugita S, Tanaka H, Kamoi K, Kawaguchi T, Mochizuki M.
    Br J Ophthalmol; 2010 Mar; 94(3):284-8. PubMed ID: 19692382
    [Abstract] [Full Text] [Related]

  • 4. Loss of efficacy during long-term infliximab therapy for sight-threatening childhood uveitis.
    Simonini G, Zannin ME, Caputo R, Falcini F, de Martino M, Zulian F, Cimaz R.
    Rheumatology (Oxford); 2008 Oct; 47(10):1510-4. PubMed ID: 18676502
    [Abstract] [Full Text] [Related]

  • 5. Cyclosporine in Behçet's disease resistant to conventional therapy.
    Caspers-Velu LE, Decaux G, Libert J.
    Ann Ophthalmol; 1989 Mar; 21(3):111-6, 118. PubMed ID: 2735696
    [Abstract] [Full Text] [Related]

  • 6. Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behçet disease.
    Tabbara KF, Al-Hemidan AI.
    Am J Ophthalmol; 2008 Dec; 146(6):845-50.e1. PubMed ID: 18929351
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Renal interstitial fibrosis and vascular changes. Occurrence in patients with autoimmune diseases treated with cyclosporine.
    Svenson K, Bohman SO, Hällgren R.
    Arch Intern Med; 1986 Oct; 146(10):2007-10. PubMed ID: 3767545
    [Abstract] [Full Text] [Related]

  • 10. Cyclosporin A in the treatment of posterior uveitis.
    Graham EM, Sanders MD, James DG, Hamblin A, Kasp Grochowska E, Dumonde D.
    Trans Ophthalmol Soc U K (1962); 1985 Oct; 104 ( Pt 2)():146-51. PubMed ID: 3857775
    [Abstract] [Full Text] [Related]

  • 11. Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study.
    Niccoli L, Nannini C, Benucci M, Chindamo D, Cassarà E, Salvarani C, Cimino L, Gini G, Lenzetti I, Cantini F.
    Rheumatology (Oxford); 2007 Jul; 46(7):1161-4. PubMed ID: 17478466
    [Abstract] [Full Text] [Related]

  • 12. Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter's syndrome.
    Kiss S, Letko E, Qamruddin S, Baltatzis S, Foster CS.
    Ophthalmology; 2003 Sep; 110(9):1764-9. PubMed ID: 13129875
    [Abstract] [Full Text] [Related]

  • 13. The efficacy of cyclosporin-a in the treatment of Behçet's disease.
    Atmaca LS, Batioğlu F.
    Ophthalmic Surg; 1994 May; 25(5):321-7. PubMed ID: 8058265
    [Abstract] [Full Text] [Related]

  • 14. Combined fluocinolone acetonide intraocular delivery system insertion, phacoemulsification, and intraocular lens implantation for severe uveitis.
    Chieh JJ, Carlson AN, Jaffe GJ.
    Am J Ophthalmol; 2008 Oct; 146(4):589-594. PubMed ID: 18639220
    [Abstract] [Full Text] [Related]

  • 15. [Effect of intravitreal and orbital floor triamcinolone acetonide injection on intraocular inflammation in patients with active non-infectious uveitis].
    Roesel M, Gutfleisch M, Heinz C, Heimes B, Zurek-Imhoff B, Heiligenhaus A.
    Klin Monbl Augenheilkd; 2009 Feb; 226(2):110-4. PubMed ID: 19206044
    [Abstract] [Full Text] [Related]

  • 16. Cyclosporine therapy for severe sight-threatening uveitis in children and adolescents.
    Walton RC, Nussenblatt RB, Whitcup SM.
    Ophthalmology; 1998 Nov; 105(11):2028-34. PubMed ID: 9818601
    [Abstract] [Full Text] [Related]

  • 17. Uveitis in Behçet disease: an analysis of 880 patients.
    Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Huseyin Altunbas H, Urgancioglu M.
    Am J Ophthalmol; 2004 Sep; 138(3):373-80. PubMed ID: 15364218
    [Abstract] [Full Text] [Related]

  • 18. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
    Cirić J, Zarković M, Stojanović M, Pepenezić Z, Randjelović G, Gligorović M, Trbojević B, Drezgić M, Nesović M.
    Srp Arh Celok Lek; 2000 Sep; 128(5-6):179-83. PubMed ID: 11089418
    [Abstract] [Full Text] [Related]

  • 19. [Cyclosporin A in therapy of chronic uveitis].
    Klein S, Friedrich R, Fricke B, Illéssy A, Bondartschuk K.
    Ophthalmologe; 1992 Oct; 89(5):411-5. PubMed ID: 1304223
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial.
    Tugal-Tutkun I, Mudun A, Urgancioglu M, Kamali S, Kasapoglu E, Inanc M, Gül A.
    Arthritis Rheum; 2005 Aug; 52(8):2478-84. PubMed ID: 16052571
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.